The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery
- 30 April 2000
- journal article
- Published by Elsevier BV in Surgery
- Vol. 127 (4), 464-471
- https://doi.org/10.1067/msy.2000.104743
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Quantitative liver function tests define the functional severity of liver disease in early-stage cirrhosisLiver Transplantation and Surgery, 1997
- The use of lidocaine as a test of liver function in liver transplantationLiver Transplantation and Surgery, 1996
- A Prediction Scoring System to Select the Surgical Treatment of Liver Cancer Further Refinement Based on 10 Years of UseAnnals of Surgery, 1994
- Assessment of lidocaine metabolite formation in comparison with other quantitative liver function testsJournal of Hepatology, 1993
- USE OF MONOETHYLGLYCINEXYLIDIDE AS A LIVER FUNCTION TEST IN THE LIVER TRANSPLANT RECIPIENT1Transplantation, 1993
- Selection criteria for liver transplant donorsJournal of Clinical Laboratory Analysis, 1991
- Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Functioncclm, 1987
- Influence of Selected Patient Variables and Operative Blood Loss on Six-Month Survival Following Liver TransplantationSeminars in Liver Disease, 1985
- The Quantitative Liver Function as Measured by the Galactose Elimination CapacityActa Medica Scandinavica, 1982
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973